Your browser doesn't support javascript.
Respiratory immune status and microbiome in recovered COVID-19 patients revealed by metatranscriptomic analyses.
Meng, Huan; Wang, Shuang; Tang, Xiaomeng; Guo, Jingjing; Xu, Xinming; Wang, Dagang; Jin, Fangfang; Zheng, Mei; Yin, Shangqi; He, Chaonan; Han, Ying; Chen, Jin; Han, Jinyu; Ren, Chaobo; Gao, Yantao; Liu, Huifang; Wang, Yajie; Jin, Ronghua.
  • Meng H; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Wang S; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Tang X; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Guo J; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Xu X; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Wang D; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Jin F; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Zheng M; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Yin S; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • He C; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Han Y; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Chen J; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Han J; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Ren C; Translational R&D Center, Guangzhou Vision Medicals Co. LTD, Guangzhou, China.
  • Gao Y; Translational R&D Center, Guangzhou Vision Medicals Co. LTD, Guangzhou, China.
  • Liu H; Translational R&D Center, Guangzhou Vision Medicals Co. LTD, Guangzhou, China.
  • Wang Y; Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Jin R; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Front Cell Infect Microbiol ; 12: 1011672, 2022.
Article in English | MEDLINE | ID: covidwho-20239652
ABSTRACT
Coronavirus disease 2019 (COVID-19) is currently a severe threat to global public health, and the immune response to COVID-19 infection has been widely investigated. However, the immune status and microecological changes in the respiratory systems of patients with COVID-19 after recovery have rarely been considered. We selected 72 patients with severe COVID-19 infection, 57 recovered from COVID-19 infection, and 65 with non-COVID-19 pneumonia, for metatranscriptomic sequencing and bioinformatics analysis. Accordingly, the differentially expressed genes between the infected and other groups were enriched in the chemokine signaling pathway, NOD-like receptor signaling pathway, phagosome, TNF signaling pathway, NF-kappa B signaling pathway, Toll-like receptor signaling pathway, and C-type lectin receptor signaling pathway. We speculate that IL17RD, CD74, and TNFSF15 may serve as disease biomarkers in COVID-19. Additionally, principal coordinate analysis revealed significant differences between groups. In particular, frequent co-infections with the genera Streptococcus, Veillonella, Gemella, and Neisseria, among others, were found in COVID-19 patients. Moreover, the random forest prediction model with differential genes showed a mean area under the curve (AUC) of 0.77, and KCNK12, IL17RD, LOC100507412, PTPRT, MYO15A, MPDZ, FLRT2, SPEG, SERPINB3, and KNDC1 were identified as the most important genes distinguishing the infected group from the recovered group. Agrobacterium tumefaciens, Klebsiella michiganensis, Acinetobacter pittii, Bacillus sp. FJAT.14266, Brevundimonas naejangsanensis, Pseudopropionibacterium propionicum, Priestia megaterium, Dialister pneumosintes, Veillonella rodentium, and Pseudomonas protegens were selected as candidate microbial markers for monitoring the recovery of COVID patients. These results will facilitate the diagnosis, treatment, and prognosis of COVID patients recovering from severe illness.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Front Cell Infect Microbiol Year: 2022 Document Type: Article Affiliation country: Fcimb.2022.1011672

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Front Cell Infect Microbiol Year: 2022 Document Type: Article Affiliation country: Fcimb.2022.1011672